California Public Employees Retirement System boosted its position in Humana Inc (NYSE:HUM) by 21.2% during the 4th quarter, Holdings Channel reports. The firm owned 435,658 shares of the insurance provider’s stock after purchasing an additional 76,138 shares during the period. California Public Employees Retirement System’s holdings in Humana were worth $108,074,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently bought and sold shares of the company. WFG Advisors LP lifted its position in shares of Humana by 4.5% during the second quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock worth $113,000 after acquiring an additional 20 shares in the last quarter. Scotia Capital Inc. lifted its position in shares of Humana by 4.8% during the second quarter. Scotia Capital Inc. now owns 2,200 shares of the insurance provider’s stock worth $529,000 after acquiring an additional 100 shares in the last quarter. Advantus Capital Management Inc lifted its position in shares of Humana by 1.4% during the third quarter. Advantus Capital Management Inc now owns 14,798 shares of the insurance provider’s stock worth $3,605,000 after acquiring an additional 203 shares in the last quarter. Cadence Capital Management LLC lifted its position in shares of Humana by 3.6% during the third quarter. Cadence Capital Management LLC now owns 5,887 shares of the insurance provider’s stock worth $1,434,000 after acquiring an additional 205 shares in the last quarter. Finally, Daiwa SB Investments Ltd. lifted its position in shares of Humana by 44.9% during the fourth quarter. Daiwa SB Investments Ltd. now owns 710 shares of the insurance provider’s stock worth $176,000 after acquiring an additional 220 shares in the last quarter. Institutional investors and hedge funds own 94.39% of the company’s stock.
Several equities research analysts have issued reports on HUM shares. Leerink Swann increased their target price on Humana from $280.00 to $300.00 and gave the stock an “outperform” rating in a research report on Thursday. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $297.00 target price on the stock in a research report on Monday, January 15th. Credit Suisse Group dropped their target price on Humana from $256.00 to $246.00 and set a “neutral” rating on the stock in a research report on Friday, November 10th. ValuEngine downgraded Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, December 19th. Finally, BMO Capital Markets started coverage on Humana in a research report on Monday, October 16th. They set an “outperform” rating and a $300.00 target price on the stock. Eight research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $269.68.
Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share for the quarter, topping the consensus estimate of $2.00 by $0.06. The firm had revenue of $13.19 billion for the quarter, compared to analysts’ expectations of $13.14 billion. Humana had a net margin of 4.55% and a return on equity of 16.13%. The business’s quarterly revenue was up 2.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.34 earnings per share. research analysts expect that Humana Inc will post 13.75 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Friday, March 30th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date of this dividend is Wednesday, March 28th. This is a boost from Humana’s previous quarterly dividend of $0.40. Humana’s dividend payout ratio is currently 9.59%.
Humana declared that its board has approved a share buyback plan on Thursday, December 14th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the insurance provider to reacquire shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its shares are undervalued.
In related news, VP Timothy S. Huval sold 1,382 shares of the stock in a transaction on Tuesday, December 19th. The stock was sold at an average price of $246.04, for a total value of $340,027.28. Following the transaction, the vice president now owns 11,557 shares of the company’s stock, valued at $2,843,484.28. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Jody L. Bilney sold 7,054 shares of the stock in a transaction on Monday, December 18th. The shares were sold at an average price of $247.89, for a total value of $1,748,616.06. Following the completion of the transaction, the senior vice president now directly owns 11,704 shares in the company, valued at approximately $2,901,304.56. The disclosure for this sale can be found here. In the last three months, insiders sold 10,115 shares of company stock worth $2,501,627. 0.80% of the stock is owned by insiders.
TRADEMARK VIOLATION NOTICE: This piece was first posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The legal version of this piece can be viewed at https://sportsperspectives.com/2018/02/10/humana-inc-hum-shares-bought-by-california-public-employees-retirement-system-2.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.